This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie policy for more information on the cookies we use and how to delete or block them.

Ok, Got It
News, stories and opinions for the business innovators of the world.

Planet Innovation and Lumos Diagnostics collaborate to establish new RAT manufacturing facility

Roger LangsdonMarketing Director

Planet Innovation (PI), Australia’s leading healthtech innovation and commercialization company, and Lumos Diagnostics (Lumos), a rapid point-of-care diagnostics company, with support from the Victorian State Government, will establish a $17.2 million Rapid Diagnostics Manufacturing Facility and Innovation Hub in Victoria to locally manufacture RATs.

Subject to necessary approvals, including those from the Therapeutic Goods Administration (TGA), the facility will produce one million tests in April 2022 and scale up to three million per month by July 2022. At full capacity, the facility will be able to make 50 million RATs each year.

Beyond COVID, the facility will be able to produce variety of diagnostic tests including those for tropical diseases, flu / influenza, reproductive health, and chronic disease management, ensuring its long-term viability.

Planet Innovation Co-CEO Stuart Elliott says the business is delighted to collaborate with Lumos Diagnostics in support of the Victorian Government’s initiative to establish a strong, sovereign capability for the manufacture of rapid diagnostics.

“PI will bring its breadth of medtech expertise to create a world class operation that will support Victoria through the current COVID pandemic and into the future, with the capabilities to produce a range of diagnostic tests,” he said.

“In conjunction with Lumos and the Victorian Government, Planet Innovation will also initiate steps for building a powerful innovation ecosystem in rapid diagnostics that will engage a range of local organisations in the advancement of Victoria’s medtech manufacturing sector.”

In addition, the project will create approximately 70 ongoing jobs, adding to Victoria’s thriving medical technology manufacturing sector that already employs thousands of Victorians across the state.

Premier Daniel Andrews said of the agreement: “Manufacturing rapid antigen tests in Victoria will protect and secure the state’s supply chain and create local jobs.

“Being able to scale up production so quickly shows the strength of Victoria’s advanced manufacturing capabilities.”

Lumos’ COVID-19 RAT test CoviDx™ will be manufactured at an existing space provided to Lumos via Planet Innovation, its founding shareholder.

Lumos Diagnostics Executive Chair Sam Lanyon said of the deal: “As a global leader in rapid point-of-care (POC) diagnostic technologies, we’re proud to work with Planet Innovation and support the Victorian Government, to manufacture and deliver critical, rapid diagnostic tests.

“Lumos will leverage its global experience, that has seen it create critical infrastructure and world-class technology in North America, to support the establishment of a Victorian manufacturing hub for rapid diagnostics.

“We are thrilled that as an organisation that was founded in Victoria, we are able to answer the call and support the creation of jobs, capability and future proof Victoria’s needs for rapid testing.”

SHARE THIS ARTICLE:
Roger Langsdon Marketing Director

Roger is the Marketing Director at Planet Innovation and a specialist marketing and communications professional with a focus on growing an organization’s reputation and revenue through strategic marketing and high-impact communications.

Related Articles.

COVID has lit a fire under diagnostic testing – here is what point-of-care companies must do to step up in time

Diagnostics

As demand for diagnostic and point-of-care (POC) testing grows, new products are coming to life faster than ever. Ben Druce, VP Strategic Design, shares insights from an expert panel discussion he hosted at the MD&M and BIOMEDigital event.

PI wins Export Award for resilience and innovation during COVID-19 pandemic

News

Planet Innovation has been recognized as a leading example of resilience, innovation and excellence at the 41st Governor of Victoria Export Awards (GOVEAs).

Prime Minister Scott Morrison congratulates PI on its “tremendous success” during tour of expanded facility

News

Prime Minister Scott Morrison and Federal Member for Chisholm Gladys Liu visited Planet Innovation to tour our expanded manufacturing and design facilities, and discuss the recently announced Patent Box tax incentive.

PI delivers record growth in FY21 with operating revenue of A$112m, up 69%

News

Planet Innovation (PI) has achieved record revenue in FY21 driven by strong growth in the global medtech sector.

Diagnostics

COVID has lit a fire under diagnostic testing – here is what point-of-care companies must do to step up in time

As demand for diagnostic and point-of-care (POC) testing grows, new products are coming to life faster than ever. Ben Druce, VP Strategic Design, shares insights from an expert panel discussion he hosted at the MD&M and BIOMEDigital event.